114 related articles for article (PubMed ID: 29534355)
21. Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group.
Staiger AM; Ziepert M; Horn H; Scott DW; Barth TFE; Bernd HW; Feller AC; Klapper W; Szczepanowski M; Hummel M; Stein H; Lenze D; Hansmann ML; Hartmann S; Möller P; Cogliatti S; Lenz G; Trümper L; Löffler M; Schmitz N; Pfreundschuh M; Rosenwald A; Ott G;
J Clin Oncol; 2017 Aug; 35(22):2515-2526. PubMed ID: 28525305
[TBL] [Abstract][Full Text] [Related]
22. Diffuse large B-cell lymphomas of immunoblastic type are a major reservoir for MYC-IGH translocations.
Horn H; Staiger AM; Vöhringer M; Hay U; Campo E; Rosenwald A; Ott G; Ott MM
Am J Surg Pathol; 2015 Jan; 39(1):61-6. PubMed ID: 25229766
[TBL] [Abstract][Full Text] [Related]
23. [Detection of 3q27 chromosomal abnormality in diffuse large B cell lymphoma using FISH on cell microarray].
Jiang HY; Li HL; Zhao T
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):73-7. PubMed ID: 18247310
[TBL] [Abstract][Full Text] [Related]
24. MYC cytogenetic status correlates with expression and has prognostic significance in patients with MYC/BCL2 protein double-positive diffuse large B-cell lymphoma.
Wang XJ; Medeiros LJ; Lin P; Yin CC; Hu S; Thompson MA; Li S
Am J Surg Pathol; 2015 Sep; 39(9):1250-8. PubMed ID: 25828389
[TBL] [Abstract][Full Text] [Related]
25. MYC protein expression is associated with poor prognosis in primary diffuse large B-cell lymphoma of the central nervous system.
Tapia G; Baptista MJ; Muñoz-Marmol AM; Gaafar A; Puente-Pomposo M; Garcia O; Marginet-Flinch R; Sanz C; Navarro JT; Sancho JM; Ribera JM; Ariza A; Mate JL
APMIS; 2015 Jul; 123(7):596-603. PubMed ID: 26010683
[TBL] [Abstract][Full Text] [Related]
26. BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma.
Kendrick SL; Redd L; Muranyi A; Henricksen LA; Stanislaw S; Smith LM; Perry AM; Fu K; Weisenburger DD; Rosenwald A; Ott G; Gascoyne RD; Jaffe ES; Campo E; Delabie J; Braziel RM; Cook JR; Tubbs RR; Staudt LM; Chan WC; Steidl C; Grogan TM; Rimsza LM
Hum Pathol; 2014 Oct; 45(10):2144-53. PubMed ID: 25090918
[TBL] [Abstract][Full Text] [Related]
27. Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma.
Stasik CJ; Nitta H; Zhang W; Mosher CH; Cook JR; Tubbs RR; Unger JM; Brooks TA; Persky DO; Wilkinson ST; Grogan TM; Rimsza LM
Haematologica; 2010 Apr; 95(4):597-603. PubMed ID: 20378577
[TBL] [Abstract][Full Text] [Related]
28. A rare MYC/BCL3 double-translocation and protein-expression in a diffuse large B-cell lymphoma.
Ohno H; Nakagawa M; Kishimori C; Fukutsuka K; Hayashida M; Izumi K; Akasaka T; Honjo G; Haga H
Leuk Lymphoma; 2019 Mar; 60(3):825-828. PubMed ID: 30187810
[No Abstract] [Full Text] [Related]
29. [Clinicopathologic and immunohistochemical study of intra-abdominal non-Hodgkin B-cell lymphoma occurring in children].
Yang WP; Zhu CD; Gong LP; Lü BB; Zou Y; Zhong HS; Xiao Q; Wu Y; Xu HY; Zeng ST; Huang H
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):759-64. PubMed ID: 20079016
[TBL] [Abstract][Full Text] [Related]
30. MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab.
Perry AM; Alvarado-Bernal Y; Laurini JA; Smith LM; Slack GW; Tan KL; Sehn LH; Fu K; Aoun P; Greiner TC; Chan WC; Bierman PJ; Bociek RG; Armitage JO; Vose JM; Gascoyne RD; Weisenburger DD
Br J Haematol; 2014 May; 165(3):382-91. PubMed ID: 24506200
[TBL] [Abstract][Full Text] [Related]
31. Impact of Double Expression of C-MYC/BCL2 Protein and Cell of Origin Subtypes on the Outcome among Patients with Diffuse Large B-Cell Lymphoma: a Single Asian Center Experience.
Teoh CS; Lee SY; Chiang SK; Chew TK; Goh AS
Asian Pac J Cancer Prev; 2018 May; 19(5):1229-1236. PubMed ID: 29801406
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
Green TM; Young KH; Visco C; Xu-Monette ZY; Orazi A; Go RS; Nielsen O; Gadeberg OV; Mourits-Andersen T; Frederiksen M; Pedersen LM; Møller MB
J Clin Oncol; 2012 Oct; 30(28):3460-7. PubMed ID: 22665537
[TBL] [Abstract][Full Text] [Related]
33. Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma.
Valentino C; Kendrick S; Johnson N; Gascoyne R; Chan WC; Weisenburger D; Braziel R; Cook JR; Tubbs R; Campo E; Rosenwald A; Ott G; Delabie J; Jaffe E; Zhang W; Brunhoeber P; Nitta H; Grogan T; Rimsza L
Am J Clin Pathol; 2013 Feb; 139(2):242-54. PubMed ID: 23355209
[TBL] [Abstract][Full Text] [Related]
34. Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma.
Horn H; Ziepert M; Wartenberg M; Staiger AM; Barth TF; Bernd HW; Feller AC; Klapper W; Stuhlmann-Laeisz C; Hummel M; Stein H; Lenze D; Hartmann S; Hansmann ML; Möller P; Cogliatti S; Pfreundschuh M; Trümper L; Loeffler M; Glass B; Schmitz N; Ott G; Rosenwald A;
Leukemia; 2015 Jul; 29(7):1564-70. PubMed ID: 25687653
[TBL] [Abstract][Full Text] [Related]
35. EZH2 overexpression in primary gastrointestinal diffuse large B-cell lymphoma and its association with the clinicopathological features.
Liu Y; Yu K; Li M; Zeng K; Wei J; Li X; Liu Y; Zhao D; Fan L; Yu Z; Wang Y; Li Z; Zhang W; Bai Q; Yan Q; Guo Y; Wang Z; Guo S
Hum Pathol; 2017 Jun; 64():213-221. PubMed ID: 28438623
[TBL] [Abstract][Full Text] [Related]
36. [Clinicopathologic significance of bcl-6 gene rearrangement and expression in three molecular subgroups of diffuse large B-cell lymphoma].
Xu FP; Liu YH; Luo XL; Zhuang HG; Li L; Luo DL; Xu J; Zhang F; Zhang MH; Du X; Li WY
Zhonghua Bing Li Xue Za Zhi; 2008 Jun; 37(6):371-6. PubMed ID: 19031715
[TBL] [Abstract][Full Text] [Related]
37. Correlation Between C-MYC, BCL-2, and BCL-6 Protein Expression and Gene Translocation as Biomarkers in Diagnosis and Prognosis of Diffuse Large B-cell Lymphoma.
Zhang Y; Wang H; Ren C; Yu H; Fang W; Zhang N; Gao S; Hou Q
Front Pharmacol; 2018; 9():1497. PubMed ID: 30666200
[TBL] [Abstract][Full Text] [Related]
38. Novel IGH and MYC Translocation Partners in Diffuse Large B-Cell Lymphomas.
Otto C; Scholtysik R; Schmitz R; Kreuz M; Becher C; Hummel M; Rosenwald A; Trümper L; Klapper W; Siebert R; Küppers R;
Genes Chromosomes Cancer; 2016 Dec; 55(12):932-943. PubMed ID: 27356265
[TBL] [Abstract][Full Text] [Related]
39. Diffuse large B-cell lymphoma with histone H3 trimethylation at lysine 27: another poor prognostic phenotype independent of c-Myc/Bcl2 coexpression.
Oh EJ; Yang WI; Cheong JW; Choi SE; Yoon SO
Hum Pathol; 2014 Oct; 45(10):2043-50. PubMed ID: 25149548
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of MYC protein expression in central nervous system diffuse large B-cell lymphoma: comparison with MYC rearrangement and MYC mRNA expression.
Son SM; Ha SY; Yoo HY; Oh D; Kim SJ; Kim WS; Ko YH
Mod Pathol; 2017 Jan; 30(1):4-14. PubMed ID: 27687005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
